Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Evozyne
Evozyne
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Evozyne
Total Funding
$144.4 M
Evozyne Summary
Company Summary
Overview
Evozyne is a company that develops protein systems. It uses generative AI to provide IgG Protease, enzymes that modulate immune response, and CRISPR, a portfolio of gene editors.
Type
Private
Status
Active
Founded
2020
HQ
Chicago, IL, US
|
view all locations
Website
https://www.evozyne.com/
Cybersecurity rating
Sectors
Technology
artificial intelligence
biotech
drug development
pharma
platform
Homepage
Linkedin
twitter
Table of Contents
Key People
Locations
Competitors
Key People
Arjun Rallapalli,
Chief Operating Officer
Linkedin
Rama Ranganathan,
Co-Founder
Linkedin
Mike Gamson,
Chief Executive Officer
Linkedin
Aris Theologis,
Chief Business Officer
Linkedin
and 4 others
Locations
View all
1 location detected
Chicago, IL
HQ
United States
2430 N Halsted Street
Competitors and Similar Companies
BERG
Technology - Private
ZielBio
Technology - Private
Genesis Therapeutics
Technology - Private
BioXcel
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top